List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Anti-Obesity Prescription Drugs Product Introduction
1.2 Global Anti-Obesity Prescription Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Anti-Obesity Prescription Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Anti-Obesity Prescription Drugs Sales in Volume for the Year 2017-2028
1.3 United States Anti-Obesity Prescription Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Anti-Obesity Prescription Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Anti-Obesity Prescription Drugs Sales in Volume for the Year 2017-2028
1.4 Anti-Obesity Prescription Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Anti-Obesity Prescription Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Anti-Obesity Prescription Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Anti-Obesity Prescription Drugs Market Dynamics
1.5.1 Anti-Obesity Prescription Drugs Industry Trends
1.5.2 Anti-Obesity Prescription Drugs Market Drivers
1.5.3 Anti-Obesity Prescription Drugs Market Challenges
1.5.4 Anti-Obesity Prescription Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Anti-Obesity Prescription Drugs Market Segment by Type
2.1.1 Pediatric
2.1.2 Adult
2.2 Global Anti-Obesity Prescription Drugs Market Size by Type
2.2.1 Global Anti-Obesity Prescription Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Anti-Obesity Prescription Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Anti-Obesity Prescription Drugs Market Size by Type
2.3.1 United States Anti-Obesity Prescription Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Anti-Obesity Prescription Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Anti-Obesity Prescription Drugs Market Segment by Application
3.1.1 Hospitals Pharmacies
3.1.2 Retail Pharmacies
3.1.3 E-commerce
3.2 Global Anti-Obesity Prescription Drugs Market Size by Application
3.2.1 Global Anti-Obesity Prescription Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Anti-Obesity Prescription Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Anti-Obesity Prescription Drugs Market Size by Application
3.3.1 United States Anti-Obesity Prescription Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Anti-Obesity Prescription Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Anti-Obesity Prescription Drugs Competitor Landscape by Company
4.1 Global Anti-Obesity Prescription Drugs Market Size by Company
4.1.1 Top Global Anti-Obesity Prescription Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Anti-Obesity Prescription Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Anti-Obesity Prescription Drugs Price by Manufacturer (2017-2022)
4.2 Global Anti-Obesity Prescription Drugs Concentration Ratio (CR)
4.2.1 Anti-Obesity Prescription Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-Obesity Prescription Drugs in 2021
4.2.3 Global Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Anti-Obesity Prescription Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Anti-Obesity Prescription Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Anti-Obesity Prescription Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Anti-Obesity Prescription Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Anti-Obesity Prescription Drugs Market Size by Company
4.5.1 Top Anti-Obesity Prescription Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Anti-Obesity Prescription Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Anti-Obesity Prescription Drugs Sales by Players (2020, 2021 & 2022)
5 Global Anti-Obesity Prescription Drugs Market Size by Region
5.1 Global Anti-Obesity Prescription Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Anti-Obesity Prescription Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Anti-Obesity Prescription Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Anti-Obesity Prescription Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Anti-Obesity Prescription Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Anti-Obesity Prescription Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Anti-Obesity Prescription Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Anti-Obesity Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Anti-Obesity Prescription Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Anti-Obesity Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Anti-Obesity Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Anti-Obesity Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 F Hoffmann La Roche Ltd
7.1.1 F Hoffmann La Roche Ltd Corporation Information
7.1.2 F Hoffmann La Roche Ltd Description and Business Overview
7.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Products Offered
7.1.5 F Hoffmann La Roche Ltd Recent Development
7.2 Orexigen Therapeutics
7.2.1 Orexigen Therapeutics Corporation Information
7.2.2 Orexigen Therapeutics Description and Business Overview
7.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Products Offered
7.2.5 Orexigen Therapeutics Recent Development
7.3 Novo Nordisk A/s
7.3.1 Novo Nordisk A/s Corporation Information
7.3.2 Novo Nordisk A/s Description and Business Overview
7.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Products Offered
7.3.5 Novo Nordisk A/s Recent Development
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Corporation Information
7.4.2 Arena Pharmaceuticals Description and Business Overview
7.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Products Offered
7.4.5 Arena Pharmaceuticals Recent Development
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Corporation Information
7.5.2 Glaxosmithkline Description and Business Overview
7.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Products Offered
7.5.5 Glaxosmithkline Recent Development
7.6 Vivus
7.6.1 Vivus Corporation Information
7.6.2 Vivus Description and Business Overview
7.6.3 Vivus Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Vivus Anti-Obesity Prescription Drugs Products Offered
7.6.5 Vivus Recent Development
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporation Information
7.7.2 Boehringer Ingelheim Description and Business Overview
7.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Products Offered
7.7.5 Boehringer Ingelheim Recent Development
7.8 Alizyme
7.8.1 Alizyme Corporation Information
7.8.2 Alizyme Description and Business Overview
7.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Alizyme Anti-Obesity Prescription Drugs Products Offered
7.8.5 Alizyme Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Anti-Obesity Prescription Drugs Industry Chain Analysis
8.2 Anti-Obesity Prescription Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Anti-Obesity Prescription Drugs Distributors
8.3 Anti-Obesity Prescription Drugs Production Mode & Process
8.4 Anti-Obesity Prescription Drugs Sales and Marketing
8.4.1 Anti-Obesity Prescription Drugs Sales Channels
8.4.2 Anti-Obesity Prescription Drugs Distributors
8.5 Anti-Obesity Prescription Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
